drugset / Trial / NCT03695822
Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome
NaSingle-groupOpen-labelTreatment
Summary
We will get the impact of mirabegron on psychological distress, urethra and bladder blood flow and c reactive protein.
Timeline
- Start
- 2018-12-24
- Primary completion
- 2019-01-21
- Completion
- 2019-01-31
Outcome
Outcome not reported
Stopped: “I did not pass the 2018 Ministry of Science and Technology research project subsidy, so I applied for the project to close the case.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | 25 mg | — |